Edge Funding

Research Funding Board

Growing opportunities
Check in often for a current list of national research funding and award opportunities with upcoming deadlines.


Ongoing

A-T Children’s Project – Research Grant Program
  • Due: LOI submission rolling
  • Funding: Up to $75,000 per year
  • Project period: 1 to 2 years
  • Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
  • Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.
Alexander von Humboldt Research Foundation – Humboldt Research Fellowship
  • Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
  • Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
  • Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
  • Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
  • Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.
Allen Institute for AI – Allen AI Young Investigators
  • Due: Rolling
  • Funding: $100,000
  • Project period:  1 to 3 years
  • Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
  • Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

 

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)
  • Due: Rolling
  • Funding: $100,000 to $1M
  • Project period:  1 to 2 years
  • Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
  • Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

 

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)
  • Due: Open
  • Funding:Up to $1M
  • Project period:  Up to 3 years
  • Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
  • Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

 

Alzheimer’s Association – Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)
  • Due: Rolling
  • Funding: Not specified
  • Project period:  Up to 3 to 12 months
  • Purpose: To provide bridge or interim funding for early career researchers who have not yet had the opportunity to fully establish their labs and acquire ongoing funding to conduct research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson’s and/or other related disorders.
  • Eligibility: Applicants must be early stage investigators (ESIs), who have completed their terminal research degree or post-graduate clinical training, whichever is later, within the past 10 years and has not previously competed successfully as a PD/PI for a substantial NIH independent research award . This grant is intended for ESI applicants who can demonstrate disruption in either their K or R or other ESI specific investigator-led award in recent months due to U.S. federal funding challenges and must provide the NIH review and/or summary.
Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals
  • Due: Rolling; submission deadlines for subsequent review ocurring on August 15
  • Funding: Up to $100,000 per year
  • Project period:  1 to 2 years
  • Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
  • Eligibility: Researchers at all levels are eligible.
Boehringer Ingelheim U.S. – Investigator-Initiated Studies(IIS)
  • Due: Open
  • Funding: Not Specified
  • Project period:  Not Specified
  • Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
  • Eligibility: Intended for U.S. based researchers.
Brutten Family Foundation – Grants
  • Due: Open
  • Funding: Not Specified
  • Project period:  Not Specified
  • Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
  • Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.
Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant
  • Due: Rolling submission
  • Funding: Up to $10,000
  • Project period:  Not specified
  • Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
  • Eligibility: Researcher should have necessary data in hand at time of application submission.
Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award
  • Due: LOI submission rolling
  • Funding: Negotiable
  • Project period:  Not specified
  • Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
  • Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.
Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants
  • Due: January 1 (Round 1); July 1 (Round 2) annually
  • Funding: $25,000-$50,000
  • Project period: 1 to 2 years
  • Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
  • Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.
Cystic Fibrosis Foundation – Student Loan Repayment Program
  • Due: During and up to 4 months after active award period
  • Funding: $14,000 per year maximum
  • Project period: One-time payment
  • Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
  • Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.
Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience
  • Due: Rolling
  • Funding: Stipend (amount not specified)
  • Project period: 1 year
  • Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
  • Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.
Diamond Blackfan Anemia Foundation – Research Grant
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
  • Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.
FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant
  • Due: Rolling (LOI)
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
  • Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.
Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants
  • Due: February 15 and August 15 annually
  • Funding: $250,000
  • Project period: 2 years
  • Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
  • Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.
Foundation for Anesthesia Education and Research (FAER) – Research Training Grants
  • Due: February 15 and August 15 annually
  • Funding: $75,000
  • Project period: 1 year
  • Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
  • Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.
Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant
  • Due: Rolling
  • Funding: $75,000
  • Project period: 1 year
  • Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
  • Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.
Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research
  • Due: Rolling LOI submission
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
  • Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.
Gateway for Cancer Research – GFCR Grant Program
  • Due: Rolling
  • Funding: $200,000 to $1.5 M
  • Project period: 2 to 5 years
  • Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
  • Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
Gateway for Cancer Research – SIO Integrative Program
  • Due: Rolling
  • Funding: $200,000 to $1.5 M
  • Project period: 2 to 5 years
  • Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
  • Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
Gateway for Cancer Research – NCI/SPORE Program
  • Due: Rolling
  • Funding: $200,000 to $800,000
  • Project period: 2 to 5 years
  • Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
  • Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
Hearst Foundations – Funding Priorities in Health
  • Due: Rolling
  • Funding: $100,000 minimum
  • Project period: Not specified
  • Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
  • Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network
 – Request for Applications
  • Due: Open; Concept Proposals accepted year-round
    • Full applications accepted by invitation
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
  • Note: ITN does not accept proposals for non-human or preclinical studies.
Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants
  • Due: Open
  • Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
  • Project period: Not specified
  • Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
  • Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.
Malan Syndrome Foundation – Research Grant Program
  • Due: Rolling
  • Funding: $30,000 per year
  • Project period: 1 to 2 years
  • Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
  • Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.
Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program
  • Due: Rolling pre-application
    • Full applications accepted by invitation
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
  • Eligibility: Open to industry and industry-academia collaborations.
NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
  • Due: Standard March dates.
  • Funding: Up to $150,000 per year
  • Project period: Up to 5 years
  • Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.
NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
  • Due: Varies by awarding IC
  • Funding: Up to $50,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
  • Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.
NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
  • Due: Varies by awarding IC
  • Funding: Up to $50,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.
NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population
  • Due: Rolling through May 7, 2029
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
  • Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.
National Institutes of Health – Career Development (K) Awards
  • New Applications due: annually on June 12, October 12
  • Renewal/Revision/Resubmission: annually on March 12, July 12, November 12
National Institutes of Health – Individual Fellowship (F) Awards
  • All Types Due: annually on April 8, August 8, December 8
National Institutes of Health – NIH Small Grant Program (R03)
  • Standard Receipt Dates: June 16, October 16
Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants
  • Due: Rolling
  • Funding: Up to $4,000
  • Project Period: 6 months.
  • Purpose: To fund statistical and/or publication support of active PeDRA Studies
  • Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.
Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals
  • Due: Rolling
  • Funding: Not specified
  • Project Period: 1 to 3 years
  • Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
  • Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.
Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program
  • Due: Rolling
  • Funding: Not specified
  • Project period: 2 years
  • Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
  • Eligibility: Applicants must be fellows or early-stage faculty.
Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals
  • Due: Rolling
  • Funding: $50,000
  • Project period: Up to 2 years
  • Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
  • Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.
Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program
  • Due: Rolling
  • Funding: Not specified.
  • Project period: 2 years
  • Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
  • Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.
Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health
  • Due: Open
  • Funding: Not specified
  • Project period: Up to 3 years
  • Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
  • Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.
The Milbank Foundation – Grants
  • Due: Open (LOIs required)
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
  • Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.
Tourette Association of America – Support for Research Consortia and Collaborative Research Projects
  • Due: Rolling (LOI)
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
  • Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.
W.K. Kellogg Foundation – Grants
  • Due: Open (LOIs accepted at any time)
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
  • Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

 

 

November

Cystic Fibrosis Foundation – CFF/NIH R01-Unfunded Award

  • Due: Rolling until November 30, 2026
  • Funding: $125,000/year
  • Project Period: 1 year
  • Purpose: To support excellent cystic fibrosis-related research projects that have been approved by the National Institutes of Health (or governmental funding agencies in other countries) but cannot be supported by available funds.
  • Eligibility: The application must have been reviewed by an NIH study section and presented to an institute council within 12 months of applying for the CF Foundation support and must have been submitted to NIH as an R01 and have an impact score of 45 or lower (1-45). If an application has been submitted to NIH multiple times, the most recent submission must have an impact score in this range. Unfunded resubmissions (A1 or other) may be submitted through this mechanism, but may be subject to additional scrutiny and must be distinct from any previously submitted NIH R01- Unfunded projects.

Susan G. Komen Foundation – Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC

  • Nominations Due: November 30, 2026 (LOI)
  • Funding: Up to $125,000
  • Project Period: 1 year
  • Purpose: To support innovative, hypothesis-driven research focused on the biological mechanisms underlying inflammatory breast cancer (IBC) that will advance understanding of IBC onset, development, metastatic dissemination, monitoring, and detection, and also encourage creative, paradigm-shifting concepts with the potential to transform current scientific perspectives and improve patient outcomes.
  • Eligibility: Independent researchers based at eligible U.S. nonprofit institutions or organizations are eligible (including those with a formal offer letter confirming an independent position and start date by January 18, 2027; U.S. citizenship is not required). Institutions may nominate only one applicant; self-nomination is not allowed. Applicants may not be the PI of an active Komen grant focused on IBC or the PI of two or more active Komen grants as of the full application deadline.


December

American Association of Immunologists – RESTORE Grant Program

  • Due: Rolling through December 1, 2026
  • Funding: Up to $100,000
  • Project Period: 1 year
  • Purpose: AAI member-led research projects funded by grants that were unexpectedly frozen or terminated by NIH or other federal government agencies for reasons other than scientific merit.
  • Eligibility: Applicant must be the Principal Investigator (PI) or co-PI of an immunology-focused NIH R-, K-, or F-series grant (including K99/R00 and F99/K00 grants), a DP2 or DP5 grant, or a grant from NSF or another U.S. federal agency, that was awarded to an eligible institution (review criteria for more details) AND was terminated in 2025 or 2026 due to non-scientific reasons. International PIs with terminated U.S. federal grants by these mechanisms will be considered if their institution qualifies. New PIs whose start-up funding through the NIH FIRST Program was awarded to an eligible institution and was terminated in 2025 or 2026 are also eligible. Please review full eligibility criteria. Two to three years of membership required (2024-2026 with 2026 dues paid in full).

American Society of Transplantation – Early Career Faculty Development Research

  • Due: December 1, 2026
  • Funding: $75,000
  • Project Period: 1 year
  • Purpose: To foster the training of early-career investigators who are within five years of their first faculty appointment in expanding preliminary findings in basic, clinical, and translational research that can serve as the basis for future individual research or career development awards in transplant science, immunobiology, and/or the treatment of transplant recipients.
  • Eligibility: Investigators must be within five years of their first faculty appointment, and must not hold a concurrent K-series award, R00 award, career development award, or similar funding mechanism. Former PIs on NIH grants supporting independent research are not eligible.

Crohn’s & Colitis Foundation – Research Fellowship Awards

  • Due: December 1, 2026 (pre-application deadline)
  • Funding: Up to $70,000
  • Project Period: Up to 3 years
  • Purpose: To support individuals in the postdoctoral phase of their career, to develop skills related to basic research investigation in the field of inflammatory bowel disease (IBD), or Crohn’s disease and ulcerative colitis.
  • Eligibility: Applicants must have an MD and/or PhD or equivalent. MDs must have two years of experience after receiving their terminal degree (one of those years must be documented research experience relevant to IBD). PhDs must have at least one year of documented post-doctoral research relevant to IBD. Proposals must include a training and mentoring plan.

Crohn’s & Colitis Foundation – Crohn’s & Colitis Foundation/NASPGHAN IBD Young Investigator Award

  • Due: December 1, 2026 (pre-application deadline)
  • Funding: Up to $70,000
  • Project Period: Up to 3 years
  • Purpose: Offered in partnership with NASPGHAN Foundation and the Crohn’s & Colitis Foundation to support research fellows or junior faculty conducting original basic or translational scientific research related to pediatric IBD.
  • Eligibility: Applicants employed by a U.S.-based, public non-profit, private non-profit, or government institution engaged in healthcare and/or health related research, who hold an MD and/or PhD or equivalent may apply. MDs must have two years of experience after receiving their terminal degree (one of those years must be documented research experience relevant to IBD). PhDs must have at least one year of documented post-doctoral research relevant to IBD. Proposals must include a training and mentoring plan.

Damon Runyon Cancer Research Foundation – Damon Runyon Quantitative Biology

  • Due: December 1, 2026
  • Funding: $76k to $80k stipend
  • Project Period: 3 years
  • Purpose: To encourage scientists, trained in fields such as mathematics, computer science, physics, engineering, and/or a related field, to pursue research careers in computational biology under the joint mentorship of leaders in both computational science (“dry lab”) and cancer biology (“wet lab”).
  • Eligibility: Applicants must have received a PhD, MD, MD/PhD, DDS, DVM, DO, or equivalent. Open to computational scientists with an interest in the intersection between quantitative biology, data science and cancer research. Basic and physician-scientists must have received their degrees no more than five years prior to the application deadline date and may apply at any time prior to their initial assistant professorship appointment (or equivalent). Applicants must not have been in their Mentors’ labs for more than 2 years prior to the application deadline date. 100% protected time required.

Dermatology Foundation (DF) & Pediatric Dermatology Research Alliance (PeDRA) – DF PeDRA Pediatric Dermatology Mid-Career Research Award

  • Due: December 1, 2026
  • Funding: Up to $300,000
  • Project Period: Up to 3 years
  • Purpose: To advance the research of an outstanding mid-career investigator studying pediatric dermatologic-related skin disorders by providing salary support and research activities, generating innovative basic, clinical, or translational findings and encouraging pursuit of institutional funding.
  • Eligibility: Mid-career investigator (MD, MD/PhD, DO, or PhD degree) within 12 years of a faculty appointment as an Assistant Professor in an accredited dermatology department/division as of January 1, 2027, with an established track record of excellence in basic, clinical, or translational science in pediatric dermatology.

Dermatology Foundation (DF) & Pediatric Dermatology Research Alliance (PeDRATransplant Research Grant Program ) – Post-Doctoral Grant

  • Due: December 1, 2026
  • Funding: Up to $75,000 per year
  • Project Period: Up to 1 year
  • Purpose: To foster the training of early-career investigators, in basic, clinical, and translational research, who have the potential to contribute to transplant science, immunobiology, and/or the treatment of transplant recipients, while encouraging continued commitment to careers in transplantation.
  • Eligibility: Applicants must have three years or less experience performing research in transplantation and/or immunology since their most recent doctoral degree. A sponsor is required. Awardees of a K-series award, individual fellowship, career development award, or other grant that supports their salary are not eligible.

Americna Society of Transplantation – Early Career Faculty Development Research

  • Due: December 1, 2026
  • Funding: Up to $75,000 per year
  • Project Period: Up to 1 year
  • Purpose: To support the training of early-career investigators who have the potential to contribute to transplant science, immunobiology, and/or the treatment of transplant recipients, while encouraging continued commitment to careers in transplantation. The grant supports the collection of preliminary data in basic, clinical, and translational research that can serve as the basis for individual research or career development awards.
  • Eligibility: Investigators must be within five years of their first faculty appointment and may not hold a concurrent K-series award, R00 award, career development award, or similar funding. A former PI on an NIH independent research grant is ineligible.

Gorlin Syndrome Alliance (GSA) & Pediatric Dermatology Research Alliance (PeDRA) – GSA-PeDRA Gorlin Syndrome Challenge Grant

  • Due: December 3, 2026
  • Funding: Up to $25,000
  • Project Period: Up to 1 year
  • Purpose: Supports basic, translational, clinical, epidemiologic, and patient-oriented research focused on pediatric basal cell carcinoma in Gorlin syndrome, including disease biology, prevention, diagnosis, surveillance, treatment, quality of life, psychosocial impacts, multidisciplinary care models, and development of patient-centered outcomes.
  • Eligibility: MD and/or PhD or equivalent investigators may apply through their institution. Pediatric dermatology training is not required. IRB or IACUC approval is required when applicable.

Gorlin Syndrome Alliance (GSA) & Pediatric Dermatology Research Alliance (PeDRA) – GSA-PeDRA Gorlin Syndrome Challenge Grant

  • Due: December 3, 2026
  • Funding: Up to $25,000
  • Project Period: Up to 1 year
  • Purpose: Supports basic, translational, clinical, epidemiologic, and patient-oriented research focused on pediatric basal cell carcinoma in Gorlin syndrome, including disease biology, prevention, diagnosis, surveillance, treatment, quality of life, psychosocial impacts, multidisciplinary care models, and development of patient-centered outcomes.
  • Eligibility: MD and/or PhD or equivalent investigators may apply through their institution. Pediatric dermatology training is not required. IRB or IACUC approval is required when applicable.

Pediatric Dermatology Research Alliance (PeDRA) & Society for Pediatric Dermatology (SPD) – Consensus Grant Program

  • Due: December 3, 2026
  • Funding: Up to $25,000 without centralized project management from PeDRA;
    $10,000 with centralized project management from PeDRA
  • Project Period: Up to 2 years
  • Purpose: Supports the development of evidence-based consensus guidelines, best practice recommendations, or consensus treatment plans for pediatric dermatologic diseases in the U.S. and/or Canada, to reduce practice variation, improve patient care, inform reimbursement and formulary decisions, and identify future research priorities.. Priority projects include addressing diseases lacking contemporary guidelines and utilizing established consensus methodologies.
  • Eligibility: Applications will be accepted by teams of three or more individuals, including one Project Lead, who must hold an MD, DO, or equivalent degree, be a member of PeDRA or the Society for Pediatric Dermatology (SPD), and be eligible to apply for grants through their institution. Priority will be given to applications that include mentorship from, or collaboration with, individuals experienced in consensus methodology. Applicants are strongly encouraged to consult with PeDRA’s Best Practices Task Force before submission.

Plastic Surgery Foundation – Directed Research Grant – Breast Surgery

  • Due: December 4, 2026
  • Funding: Up to $50,000
  • Project Period: 2 years
  • Purpose: To support plastic surgeons pursuing research related to all aspects of breast surgery, including the critical area of breast implant safety. Research goals may range from pilot projects aimed at collecting preliminary data, up to more advanced research studies that may have an immediate impact on patient care.
  • Eligibility: Applicants must be an MD, DO, or PhD, hold a full-time clinical or research position, and be an Active, Candidate, International, or Associate member of ASPS or be able to obtain sponsorship from an Active ASPS member at their institution.

Plastic Surgery Foundation – National Endowment for Plastic Surgery

  • Due: December 4, 2026
  • Funding: Up to $50,000
  • Project Period: 2 years
  • Purpose: To support research projects that translate clinical or basic science research findings into clinically relevant advancements or tools with a high potential to impact daily practice and patient care within the next few years.
  • Eligibility: Applicants must be an MD, DO, or PhD, hold a full-time clinical or research position, and be an Active, Candidate, International, or Associate member of ASPS or be able to obtain sponsorship from an Active ASPS member at their institution. Residents who are applying must verify that they will have a year of dedicated research times to serve as a PI.

Plastic Surgery Foundation – Pilot Research Grant

  • Due: December 4, 2026
  • Funding: $15,000
  • Project Period: 1 year
  • Purpose: To support residents and junior faculty seeking to obtain preliminary data to support larger grant proposals in the future and build an independent career in academic research.
  • Eligibility: Applicants must be an MD, DO, or PhD, hold a full-time clinical or research position, and be an Active, Candidate, International, or Associate member of ASPS or be able to obtain sponsorship from an Active ASPS member at their institution.

St. Baldrick’s Foundation – Allied World – St. Baldrick’s Foundation Survivorship and Supportive Care Research Grant Award

  • Due: December 8, 2026 (LOI)
  • Funding: Up to $50,000
  • Project Period: 1 year
  • Purpose: To support hypothesis-driven basic, clinical, translational, or epidemiologic research focused on survivorship and supportive care for children and adolescents with cancer, including treatment-related complications, quality of life, patient-reported outcomes, health communication, health promotion, psychosocial support, and care across the continuum from diagnosis through survivorship or end-of-life care.
  • Eligibility: Applicants must hold a PhD, DNP, MD, or DO, and be employed by an eligible academic or nonprofit research institution or laboratory located in the U.S (U.S. citizenship is not required). Research projects must have direct applicability to pediatric cancer. Institutions are limited to one submission per funding category.

St. Baldrick’s Foundation – 2027 St. Baldrick’s Foundation Scholar (Career Development) Awards

  • Due: December 8, 2026 (LOI)
  • Funding: Up to $330,000
  • Project Period: 3 years; 2 additional years possible based on progress
  • Purpose: To help promising early career researchers to establish independent research careers and advance basic, clinical, translational, or epidemiological studies that have direct relevance to pediatric cancer research.
  • Eligibility: Applicants must hold an MD, DO, or PhD (held for no more than 7 years at the start of the award) and be employed as full-time faculty at an academic or nonprofit research institution in the U.S. (U.S. citizenship not required), and must not have had an NIH R01, R01-equivalent award, NIH K-award, or comparable career development award at the time of the LOI. A mentor and at least 40% protected time is required. One submission per funding category per institution is allowed.

Rita Allen Foundation – Rita Allen Foundation Scholars Award in Pain

  • Due: December 9, 2026
  • Funding: $150,000
  • Project Period: Over 3 years
  • Purpose: To support early-career leaders in basic pain research whose work is innovative, focused on basic science mechanisms of pain, and holds high potential for discovering new pathways to improve the treatment of chronic pain.
  • Eligibility: Applicants must be appointed faculty in the early stages of their career (within three years of the start date of a tenure track position or equivalent), with start-up funding and independent lab space provided by their institution. Applicants must demonstrate commitment to the field of pain research.

Research to Prevent Blindness (RPB) – RPB Career Development Award

  • Due: December 15, 2026 (nominations due)
  • Funding: $350,000
  • Project Period: Over 4 years
  • Purpose: To help RPB-supported ophthalmology Chairs provide mentored support for junior faculty who have demonstrated their potential for independent research.
  • Eligibility: Candidates must have an MD, MD/PhD, PhD, or equivalent, hold a primary academic position up to and including Assistant Professor (first full-time ophthalmology faculty appointment must have been within 3 years of the application deadline), and be either U.S. citizens or permanent residents (green card holder) by application deadline. 50% protected time is required.
    – RPB /Tom Wertheimer Career Development Award in Data Science – focuses on vision research using artificial intelligence and data science to gain new knowledge about sight-threatening conditions.
    – RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award – a partnership with the Mary Tyler Moore Vision Initiative (a $300,000 research award) focused on retinal research with an emphasis on expanding relevant knowledge and developing methods to preserve and restore visual function in diabetic retinopathy, diabetic macular edema, and diabetic retinal neurodegeneration known as Diabetic Retinal Disease, or DRD)
    – RPB Career Development Award – no specific focus; open to any vision-related research.

Research to Prevent Blindness (RPB) – RPB International Research Collaborators Award

  • Due: December 15, 2026 (nominations due)
  • Funding: $75,000
  • Project Period: Not specified
  • Purpose: To promote international collaborations in vision research that have the potential to accelerate the development of treatments for blinding disorders. Through these collaborations researchers in the U.S. and outside the U.S. will gain new knowledge and skills.
  • Eligibility: Full-time department Chairs at any higher education institution in the U.S. may nominate one candidate per department. Interim or acting Chairs are not allowed to nominate candidates. Candidates must hold a primary academic position as Assistant Professor through full Professor (MD, PhD, or MD/PhD) and be full-time faculty in their primary appointment by the application deadline. Early career investigators are encouraged to apply.

Research to Prevent Blindness (RPB) – RPB Walt and Lilly Disney Award for Amblyopia

  • Due: December 15, 2026 (nominations due)
  • Funding: $150,000
  • Project Period: Up to 2 years
  • Purpose: Supports research to improve the understanding, diagnosis, and/or treatment of amblyopia. Proposed projects must clearly address the pathophysiology, diagnosis, and/or treatment of amblyopia.
  • Eligibility: Full-time faculty (at application deadline) at U.S. academic institutions holding appointments as Assistant Professor, Associate Professor, or Professor (MD, PhD, or MD/PhD). Applicants must be nominated by a full-time department chair (one nominee per department), and provide at least 5% effort.

Pfizer – BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple Myeloma

  • Due: December 18, 2026
  • Funding: $250,000
  • Project Period: 1 year
  • Purpose: To support independent medical education programs designed to increase healthcare professional (HCP) competence, clinical confidence, and multidisciplinary coordination in the safe and effective use of BCMA-directed bi-specific antibodies (BsAbs) in the 2nd line and later (2L+) relapsed/refactory multiple myeloma (RRMM) setting.
  • Eligibility: Applicant PIs must be affiliated with medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. Requesting organization must be legally able to receive award funding directly from Pfizer Inc.

The Mark Foundation for Cancer Research – ASPIRE Awards (Accelerating Scientific Platforms and Innovative Research RFP

  • Due: December 18, 2026 (concept letters)
  • Funding: Up to $500,000
  • Project Period: Up to 2 years
  • Purpose: To support proposals that address these complementary challenges and accelerate the development of new strategies to target the chordoma surfaceome.
  • Eligibility: Applicant PIs must be independent researchers at a non-profit academic or research institution.

ThermoFisher – PrestIgE Award

  • Due: December 31, 2026
  • Funding: $25,000
  • Project Period: One payment
  • Purpose: To encourage U.S. allergy fellows to engage in molecular allergy diagnostic research activities, with an emphasis on allergen components.
  • Eligibility: Applicants should have a history of relevant scholarship and/or research in allergy diagnosis and treatment. Specific proposal should outline how this grant’s funding will aid in the progression and understanding of allergen components and allergy diagnostics.


Awards

December

 

Camille and Henry Dreyfus Foundation – Dreyfus Prize in the Chemical Sciences

  • Nominations Due: December 3, 2026
  • Funding: $250,000
  • Purpose: Awarded to an individual in a selected area of chemistry to recognize exceptional and original research that has advanced the field in a major way. 2027 Area of Interest: Chemical Probes of Biological Systems. Any person may nominate a candidate for the Dreyfus Prize. Self-nominations are not accepted.
  • Eligibility: The Prize is open to international nominations. Up to three letters of support are accepted for each nomination.

January 2027

Pediatric Dermatology Research Alliance (PeDRA) & Arthritis National Research Foundation (ANRF) – Rheum for Kids: Pediatric Skin and Joint Grant

  • Due: January 8, 2027
  • Funding: Up to $50,000
  • Project Period: Up to 1 year
  • Purpose: To support innovative research in pediatric rheumatology and dermatology, that advances understanding of disease mechanisms and fosters collaborative, cross-disciplinary research teams spanning pediatric dermatology and pediatric rheumatology.
  • Eligibility: Promising early-career investigators with a strong record and a clear upward career trajectory, ideally within 7 years of their most recent training with strong mentorship support may apply. Areas of priority: projects that address both skin and joint disease and involve expertise from both pediatric rheumatology and pediatric dermatology. Topics may include juvenile arthritis, psoriasis, lupus, dermatomyositis, morphea, and other diseases affecting both the skin and joints.

The Leakey Foundation – Research Grants Program

  • Due: January 10, 2027 (Spring Cycle)
  • Funding: U to $30,000 (PhD researchers)
  • Project Period: Not specified
  • Purpose: Supports research on human origins and evolution, including dissertation and exploratory studies in paleoanthropology, archaeology, biological anthropology, primatology, genetics, and related fields.
  • Eligibility: Advanced PhD candidates (with everything except their dissertation completed) and researchers at all stages of their careers who are affiliated with a university, museum, or similar institution.

Thrasher Research Fund – E.W. “Al” Thrasher Awards

  • Due: January 12, 2027 (concept deadline)
  • Funding: Up to $600,000
  • Project Period: Up to 3 years
  • Purpose: To support innovative, novel research focused on any disease or topic within the umbrella of pediatrics that has the potential to improve health outcomes in children or have broad applicability to the field. Solutions that can quickly be implemented in clinic will have priority.
  • Eligibility: PIs from institutions world-wide who hold a doctoral degree may apply.

Simons Foundation – Fellows-to-Faculty – 2027 Request for Applications

  • Due: January 13, 2027
  • Funding: $600,000
  • Project Period: Over 3 years
  • Purpose: To support exceptional early-career scientists transitioning from mentored research positions to independent tenure-track faculty careers who will help to expand and strengthen the communities of researchers advancing the basic science missions of the Simons Foundation Autism Research Initiative (SFARI), Simons Collaboration on Plasticity and the Aging Brain (SCPAB), and Simons Collaboration on Ecological Neuroscience (SCENE).
  • Eligibility: Applicants must hold a PhD, MD, or equivalent and currently be in a mentored research training position (i.e.: postdoctoral fellowship) with plans to seek tenure-track research faculty positions during the upcoming academic job cycle and have research interests aligned with the scientific priorities of SFARI, SCPAB, or SCENE.

Whitehall Foundation – Research Grants

  • Due: January 15, 2027
  • Funding: $100,000 per year
  • Project Period: Up to 3 years
  • Purpose: To support early career scientists at the beginning of their careers who are pursuing research in the life sciences, in areas of biological research that are not heavily supported by Federal Agencies or foundations with specialized missions.
  • Eligibility: Faculty must be an independent investigator at the Assistant Professor or Assistant Research Professor level at the time of application. Eligible applicants may not have more than $200,000 per year in extramural funding.

Whitehall Foundation – Grants-in-Aid

  • Due: January 15, 2027
  • Funding: $30,000
  • Project Period: Up to 1 year
  • Purpose: To support researchers with innovative proposals who have difficulty competing for research funds because they are not yet established.
  • Eligibility: Independent investigators at the Assistant Professor or Assistant Research Professor level at the time of application may apply.

Simons Foundation – Scientific Software Research Faculty Award – 2027–2028 RFA

  • Due: January 21, 2027 (LOI)
  • Funding: Salary support (year 1 & 2: 100% salary support & fringe; year 3-5: 50% salary; $50,000 per year research allowance
  • Project Period: Up to 5 years
  • Purpose: To support new faculty-level positions for researchers who lead the development and maintenance of broadly used scientific software in mathematics, astronomy, theoretical physics, and related quantitative disciplines.
  • Eligibility: Applicants must hold a PhD or equivalent and have a demonstrated leadership role in the above mentioned fields. Awardees must be hired into a new research professor, professor of practice, clinical professor, or equivalent faculty position that is not term-limited and permits PI status. Institutional funding is required to supplement years 3 through 5.

RSNA Research & Education (R&E) Foundation – Research Seed Grant

  • Due: January 22, 2027
  • Funding: Up to $60,000
  • Project Period: Up to 1 year
  • Purpose: To help investigators launch new research projects, test hypotheses, and generate preliminary/pilot data to help obtain future funding from external funders (corporations, foundations, government agencies).
  • Eligibility: Investigators with a full-time faculty position in radiology, radiation oncology, or nuclear medicine at an educational institution may apply. Active RSNA membership is required. Future faculty appointees may apply with written support from their department chair.

RSNA Research & Education (R&E) Foundation – Research Scholar Grant

  • Due: January 22, 2027
  • Funding: Up to $200,000
  • Project Period: Up to 2 years
  • Purpose: To support junior faculty in radiologic sciences who have completed residency and fellowship but are not yet independent investigators, by providing funding to gain research experience and generate preliminary data to obtain future funding.
  • Eligibility: For RSNA members in good standing. Full-time faculty or equivalent, in radiologic sciences at a North American educational institution, within 8 years of initial instructor/assistant professor or equivalent faculty appointment may apply. Applicants must not have been a PI on external/extramural grants or contracts totaling more than $60,000 in a single year. 20% effort is required. Institutions may submit no more than 2 applications per cycle.

The Marfan Foundation – Isabella Noelani Parson Welch Memorial Grant for VEDS Research

  • Due: January 25, 2027
  • Funding: Up to $125,000
  • Project Period: 2 years
  • Purpose: To support innovative basic, translational, or clinical research focused specifically on advancing understanding of Vascular Ehlers-Danlos syndrome (VEDS) and accelerating discoveries that improve the diagnosis and management of the condition and ultimately improve outcomes for people living with VEDS.
  • Eligibility: The PI must hold an MD, DO, PhD, ScD, DDS, DVM, or equivalent and must have demonstrated ability to conduct independent research, evidenced by original research publications in peer-reviewed journals. Researchers from any discipline may apply.

The Marfan Foundation – Victor McKusick Fellowship

  • Due: January 25, 2027
  • Funding: Up to $100,000 (PhDs) to $150,000 (MDs)
  • Project Period: Up to 2 years
  • Purpose: Intended to support career development with formal education and experience in research methodologies which involves the fellow in the conception, planning, execution, and reporting of research related to Marfan syndrome, VEDS, LDS, other genetic aortic and vascular conditions, and Stickler syndrome.
  • Eligibility: The applicant must hold an MD, DO, PhD, ScD, DDS, DVM, or equivalent. Fellows should be eligible at their institution for specialty training in the field of Marfan syndrome and related conditions, including but not limited to genetics, cardiology, orthopedics, pulmonary, and ophthalmology. Fellowships can be offered up to the postgraduate year 6. The PI’s mentor must have a proven ability to pursue independent research–evidenced by original research publications in peer-reviewed journals and/or support from extramural funding sources. The mentor may be in any department within the applicant’s institution.

Advancing Craniosynostosis Treatment (ACT) Rare Diseases Consortium – Pilot Study Program (Cycle 2) RFP

  • Due: January 31, 2027
  • Funding: Up to $40,000
  • Project Period: Up to 12 months
  • Purpose: To support early-stage, high-impact clinical pilot research to advance diagnosis, clinical trial readiness, and management/treatment of syndromic craniosynostosis, and to allow researchers to generate preliminary data, validate novel concepts, or de-risk innovative approaches aligned with ACT Clinical Projects 1–3.
  • Eligibility: PI must be based at a U.S.-based academic or research institution and hold a doctoral-level degree.


February 2027

Rare Organic Acidemias Research (ROAR) Consortium – Early Career Fellowship

  • Due: February 1, 2027
  • Funding: $50,000
  • Project Period: 1 year
  • Purpose: To support an early career physician-researcher or a postdoctoral trainee seeking to conduct a clinical research project focused on organic acidemias (no animal research), with structured mentoring and participation in ROAR/RDCRN training and consortium activities to build a career in rare metabolic disorders research.
  • Eligibility: Postdoctoral trainee or early career faculty within 5 years of residency/fellowship as of April 15, 2027; applicants may be within or outside ROAR but must have a mentor or co-mentor who is a ROAR consortium member.

Rare Organic Acidemias Research (ROAR) Consortium – Camille Dreyfus Teacher-Scholar Awards Program

  • Due: February 4, 2027
  • Funding: Up to $100,000
  • Project Period: Not specified
  • Purpose: To support the research and teaching careers of talented early career faculty in the chemical sciences.
  • Eligibility: Open to faculty from academic institutions in the U.S. Districts, and Territories of the United States of America that grant a bachelor’s or higher degree in the chemical sciences, including chemistry, biochemistry, materials chemistry, and chemical engineering. Candidates must be within the first six years of their independent academic career at the time of submission of the nomination, and be full-time, tenure-track faculty focused on the chemical sciences in a Ph.D.-granting department that is fully engaged in conducting scholarly research and where undergraduate education is an important component of the program.

 

Gerber Foundation – Emerging Investigator Award

  • Due: February 10, 2027 (concept paper)
  • Funding: $50,000
  • Project Period: Not specified
  • Purpose: To support promising emerging early career investigators by providing funding and mentorship opportunities to help them conduct their first mentored pediatric research project, generate preliminary data, and build the skills and experience needed for a sustained career in child health research.
  • Eligibility: Applicant PIs must be early-career investigators establishing independent research programs (K12 awardees or applicants who have not previously received NIH K- or R-series awards).

Gerber Foundation – Pediatric Research Award

  • Due: February 10, 2027 (concept paper)
  • Funding: $350,000
  • Project Period: Not specified
  • Purpose: To support promising emerging early career investigators by providing funding and mentorship opportunities to help them conduct their first mentored pediatric research project, generate preliminary data, and build the skills and experience needed for a sustained career in child health research.
  • Eligibility: Applicant PIs must be early-career investigators establishing independent research programs (K12 awardees or applicants who have not previously received NIH K- or R-series awards).


March 2027

American Society of Transplantation (AST) – Transition to Independence Research Grants

  • Due: March 15, 2027
  • Funding: $100,000-$150,000
  • Project Period: Up to 2 years
  • Purpose: The grant supports an early career investigator’s transition to an independent research award in basic, clinical, and translational research focused on solid organ transplantation and/or immunology related to solid organ transplantation.
  • Eligibility: Academic investigators developing an independent research program in solid organ transplantation and/or transplant-related immunology may apply. Former PIs on an NIH grant supporting independent research are ineligible.

Thrasher Research Fund – Early Career Awards

  • Due: March 16, 2027 (concept submission)
  • Funding: Up to Up to $600,000
  • Project Period: Up to 3 years
  • Purpose: To provide small grants for pediatric-related studies to new researchers to help them establish careers as independent researchers.
  • Eligibility: PI applicants who are in a residency/fellowship training program no more than one year before the Concept Paper deadline, and postdoctoral researchers who received the doctoral degree no more than three years before the Concept Paper deadline may apply.

April 2027

Team Jack Foundation – Brain Tumor Research Grants

  • Due: Rolling up to April 30, 2027
  • Funding: Not specified
  • Project Period: Up to 3 years
  • Purpose: To support basic and translational studies with potential to advance understanding of underlying biology of the development and treatment of pediatric brain cancer and also discovery of more effective treatments and a cure for brain tumors in children.
  • Eligibility: Investigators at any level may apply.
    Note: Scientists may submit their letter of intent at anytime throughout the year but no later than April 30 for consideration the same year. Submitted grants are reviewed only once per year.
Questions
Email the Edge team at info@edgeforscholars.org
upcoming Research Funding Board events [ view all events ]
December 7, 2026 | 1:00 pm (In-Person) Dr. Todd Edwards & Dr. Digna Velez Edwards | Room MCE 8380 B
Workshop
Mentoring
Mid career faculty
Senior faculty
January 14, 2027 | 12:00 pm (In-Person) Panel Discussion | Location TBA
EFS Seminar
Mentoring
Pre/Post Doc
Early career faculty
January 28, 2027 | 12:00 pm (Virtual) Dr. Stephany Duda and Dr. Alvin Jeffery
EFS Seminar
Productivity
Life Hacks
Pre/Post Doc
Early career faculty
January 29, 2027 | 9:00 am (In-Person) Student Life Center
Forum
Doing Research
Pre/Post Doc
Early career faculty
Mid career faculty
Senior faculty
February 4, 2027 | 12:00 pm (In-Person) Panel Discussion | Location TBA
EFS Seminar
Grants & Funding
Writing & Publishing
February 18, 2027 | 12:00 pm (Virtual) Dr. Alvin Jeffery
EFS Seminar
Faculty Life
Pre/Post Doc
Early career faculty
February 25, 2027 | 12:00 pm (Virtual) Dr. Evan Brittain
EFS Seminar
Faculty Life
Early career faculty
March 4, 2027 | 12:00 pm (Virtual) Dr. Antentor Hinton
EFS Seminar
Writing & Publishing
Pre/Post Doc
Early career faculty
Testimonials
Success

Assistant Professor

Department
Obstetrics & Gynecology, Division of Quantitative & Division of General Obstetrics
Award Type
  • K01 Recipient

Assistant Professor

Department
Anesthesiology; Biomedical Informatics
Award Type
  • R01

Instructor

Department
Dermatology
Award Type
  • K08

Research Associate Professor

Department
Orthopaedic Surgery & Physical Medicine and Rehabilitation
Award Type
  • R01



find out first